Knoth J, Viveros O H, Diliberto E J
Department of Medicinal Biochemistry, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709.
J Biol Chem. 1987 Oct 15;262(29):14036-41.
Primary cultures of bovine adrenomedullary cells actively take up ascorbic acid and alpha-aminoisobutyric acid (AIB). Following a brief incubation with L-[14C] ascorbic acid and alpha-[methyl-3H]aminoisobutyric acid, cells stimulated with the nicotinic agonist 1,1-dimethyl-4-phenylpiperazinium iodide or by membrane depolarization with high [K+] or veratridine released newly acquired ascorbic acid (NA-ascorbate) and AIB. NA-ascorbate and endogenous catecholamines are differentially released under a variety of conditions suggesting that release of both substances cannot originate from the same subcellular compartment. In contrast, the release profile for NA-ascorbate and AIB, a putative cytosolic marker, suggest that both of these molecules are released from a cytosolic compartment. Cells permeabilized with the detergent digitonin release catecholamines only in the presence of external Ca2+, whereas release of NA-ascorbate and AIB is Ca2+-independent and time- and detergent concentration-dependent. If the osmolality of the external medium is made either hyper- or hypoosmotic, 1,1-dimethyl-4-phenylpiperazinium iodide-induced release of endogenous catecholamines is inhibited. Release of NA-ascorbate and AIB, however, is progressively inhibited with increasing osmolality and enhanced with decreasing osmolality. Furthermore, differential release of NA-ascorbate and AIB as compared to soluble acetylcholinesterase, which is apparently released form the cisternae of the endoplasmic reticulum, was also observed. To determine the mechanism by which NA-ascorbate and AIB are released from the cell, the requirements for their maximal release were investigated. Release of NA-ascorbate and AIB was sensitive to inhibitors (both metabolic and transport) and to changes in the external ionic environment. The metabolic inhibitors carbonyl cyanide p-trifluoromethoxyphenylhydrazone and KCN (when incubated simultaneously with 2-deoxyglucose) inhibited NA-ascorbate and AIB release by greater than 75%. In contrast, the Na+-K+-ATPase inhibitor ouabain enhanced veratridine-induced release of NA-ascorbate by nearly 100% and had an even greater effect on AIB release. Changes in the external ionic environment (i.e. Na+ and/or Cl- substitution) inhibited both NA-ascorbate and AIB release to varying degrees. Substitution of Cl- by various anions inhibited NA-ascorbate and AIB release to a much greater degree than endogenous catecholamine release. Complete substitution of NaCl with sucrose inhibited release of NA-ascorbate and AIB release by greater than 80%, while Na+ substituted with Li+ inhibited release of all three molecules by about 50%.(ABSTRACT TRUNCATED AT 400 WORDS)
牛肾上腺髓质细胞的原代培养物能主动摄取抗坏血酸和α-氨基异丁酸(AIB)。在用L-[14C]抗坏血酸和α-[甲基-3H]氨基异丁酸短暂孵育后,用烟碱激动剂碘化1,1-二甲基-4-苯基哌嗪或用高[K+]或藜芦碱使细胞膜去极化刺激细胞,可释放新摄取的抗坏血酸(NA-抗坏血酸盐)和AIB。在多种条件下,NA-抗坏血酸盐和内源性儿茶酚胺的释放存在差异,这表明这两种物质的释放并非源自同一亚细胞区室。相比之下,NA-抗坏血酸盐和AIB(一种假定的胞质标记物)的释放模式表明这两种分子均从胞质区室释放。用去污剂洋地黄皂苷通透处理的细胞仅在存在细胞外Ca2+时释放儿茶酚胺,而NA-抗坏血酸盐和AIB的释放不依赖Ca2+,且与时间和去污剂浓度有关。如果使细胞外介质的渗透压变为高渗或低渗,碘化1,1-二甲基-4-苯基哌嗪诱导的内源性儿茶酚胺释放会受到抑制。然而,NA-抗坏血酸盐和AIB的释放会随着渗透压升高而逐渐受到抑制,随着渗透压降低而增强。此外,还观察到与可溶性乙酰胆碱酯酶相比,NA-抗坏血酸盐和AIB的差异释放,可溶性乙酰胆碱酯酶显然是从内质网池释放的。为了确定NA-抗坏血酸盐和AIB从细胞中释放的机制,研究了它们最大释放的条件。NA-抗坏血酸盐和AIB的释放对抑制剂(代谢和转运方面的)以及细胞外离子环境的变化敏感。代谢抑制剂羰基氰对三氟甲氧基苯腙和KCN(与2-脱氧葡萄糖同时孵育时)抑制NA-抗坏血酸盐和AIB释放超过75%。相比之下,Na+-K+-ATP酶抑制剂哇巴因使藜芦碱诱导的NA-抗坏血酸盐释放增加近100%,对AIB释放的影响更大。细胞外离子环境的变化(即Na+和/或Cl-替代)不同程度地抑制了NA-抗坏血酸盐和AIB的释放。用各种阴离子替代Cl-对NA-抗坏血酸盐和AIB释放的抑制程度远大于对内源性儿茶酚胺释放的抑制。用蔗糖完全替代NaCl抑制NA-抗坏血酸盐和AIB释放超过80%,而用Li+替代Na+抑制所有三种分子的释放约50%。(摘要截取自400字)